Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

Generate Capital PBC, an investment firm that has raised more than $14 billion since 2014 to bankroll largely US-based sustainable projects, has cut staff as the withdrawal of US policy support upends ...

STAY WITH WMUR BOTH ON AIR AND ONLINE FOR THE LATEST ON THIS DEVELOPING STORY... WE'LL ALSO HAVE ALL OF THE OVERNIGHT DEVELOPMENTS ON NEWS 9 DAYBREAK ONE OF THE GRANITE STATE'S LARGEST SOLAR PROJECTS ...

The following content is brought to you by Mashable partners. If you buy a product featured here, we may earn an affiliate commission or other compensation. Really lean into the AI fun with this $40 ...

Ezra Levin, co-executive director of Indivisible, talks with Rachel Maddow about the success of anti-Trump protests so far, and the remarkable participation in the massive day of protests planned for ...

Facebook owner Meta announced on Friday it had built a new AI model called Movie Gen that can create realistic-seeming video and audio clips in response to user prompts, claiming it can rival tools ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate:Biomedicines (“Generate”) today announced a multi-target collaboration with Novartis (NYSE: NVS) to discover and develop protein therapeutics across ...